Oklahoma anti-choice legislators’ attempt to ban abortion via the common drug mifepristone is now on hold while a judge considers legal challenges to the new restriction.
Via ABC News:
The judge’s temporary injunction prevents House Bill 1970 from taking effect on Nov. 1. The measure requires doctors to follow strict guidelines and protocols authorized by the U.S. Food and Drug Administration, and prohibits off-label uses of abortion-inducing drugs.
“We’re thrilled that women in Oklahoma will continue to be able to access medical care that accounts for scientific evidence, sound medical judgment and advancements in medicine,” said Michelle Movahed, an attorney for the New York-based Center for Reproductive Rights, which challenged the law on behalf of Nova Health Systems, a Tulsa reproductive health care facility, and Oklahoma Coalition for Reproductive Justice, a nonprofit abortion rights group.
Appreciate our work?
Rewire is a non-profit independent media publication. Your tax-deductible contribution helps support our research, reporting, and analysis.
Movahed argued during a hearing Tuesday that off-label uses of drugs are common and that the law is bad for women’s health.
Anti-choice advocates argue that they aren’t trying to limit abortion access, but only protect women from potentially harmful side effects that could accompany the drugs.